Target
Cyclin-dependent kinase 2
Ligand
BDBM50312750
Substrate
n/a
Meas. Tech.
ChEMBL_615646 (CHEMBL1104220)
IC50
24±n/a nM
Citation
 Zeng, QBourbeau, MPWohlhieter, GEYao, GMonenschein, HRider, JTLee, MRZhang, SLofgren, JFreeman, DLi, CTominey, EHuang, XHoffman, DYamane, HTasker, ASDominguez, CViswanadhan, VNHungate, RZhang, X 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorg Med Chem Lett 20:1652-6 (2010) [PubMed]  Article
Target
Name:
Cyclin-dependent kinase 2
Synonyms:
CDK2 | CDK2-Kinase | CDK2_HUMAN | CDKN2 | Cell division protein kinase 2 | Cyclin-dependent kinase 2 (CDK2) | Protein cereblon/Cyclin-dependent kinase 2 | p33 protein kinase
Type:
Enzyme Subunit
Mol. Mass.:
33938.17
Organism:
Homo sapiens (Human)
Description:
P24941
Residue:
298
Sequence:
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
  
Inhibitor
Name:
BDBM50312750
Synonyms:
(S)-N1-(5-(1H-indazol-5-yl)-1,3,4-thiadiazol-2-yl)-3-(4-(trifluoromethyl)phenyl)propane-1,2-diamine | CHEMBL1081628
Type:
Small organic molecule
Emp. Form.:
C19H17F3N6S
Mol. Mass.:
418.439
SMILES:
N[C@H](CNc1nnc(s1)-c1ccc2[nH]ncc2c1)Cc1ccc(cc1)C(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: